Privia Health Group, Inc. Common Stock (PRVA) is a publicly traded Healthcare sector company. As of July 5, 2026, PRVA trades at $27.36 with a market cap of $3.45B and a P/E ratio of 152.00. PRVA moved +1.69% today. Year to date, PRVA is +14.67%; over the trailing twelve months it is +24.82%. Its 52-week range spans $18.77 to $27.52. Analyst consensus is strong buy with an average price target of $30.60. Rallies surfaces PRVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PRVA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $27.36 |
| Market Cap | $3.45B |
| P/E Ratio | 152.00 |
| EPS | $0.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.52 |
| 52-Week Low | $18.77 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.25B |
| Net Income | $27.39M |
| Gross Margin | 0.00% |
11 analysts cover PRVA: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.60.